The most well-established and extensively studied options are the GLP-1 receptor agonists, which have fundamentally changed the medical approach to weight management in recent years
Contrasting with these growth-inhibitory actions of IGFBPs, there is also clear evidence of growth promotion by IGFBPs in both cancer and non-cancer cells, as well as extensive clinical data linking high IGFBP expression in a variety of cancers to a more aggressive phenotype and poor patient survival [17]
Frozen Detox: 13-1-13658-5-0017
or (3) elevated filling pressures at rest or with exercise (by invasive hemodynamic measurement or echocardiography)
Mice given extra GLP-1 (via gene therapy or a GLP-1 agonist drug) developed more oxidative, fatigue-resistant muscle fibers (more Type I fibers), built up greater muscle glycogen stores, and increased mitochondrial biogenesis changes that enhanced their endurance performance (1)
That is a branding and transparency issue, not necessarily a safety issue